Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Agree. It will be interesting to see the higher dose numbers on moderate to severe. I assume the numbers should look a lot better than the phase 2 lower dose on mild-moderate. Especially using that scale - must be greater than 2 point reduction.

Mild to moderate treatment is where the big money will come in though. Especially if P can prove less side effects as an oral and better efficacy.

Jmo